An enhanced prenatal screening that is carried out in the second trimester is called the HHD Quadruple Marker Test. Four distinct chemicals are analyzed in the mother’s blood to assess the possibility of chromosomal disorders like neural tube abnormalities, trisomy 18, and Down syndrome. This test from HHD helps predict and manage possible genetic issues by providing a highly informed, non-invasive risk assessment. With the help of thorough consultation and fast, precise results from the skilled staff at HHD, expectant parents may move forward with confidence and peace of mind regarding the health of their unborn child.